articleJournal of Biological ChemistryMar 20, 2005HYBRID OA

Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling

UConn Health · University of Missouri–Kansas City · +1 more institution

PubMed
Indexed incrossrefdoajpubmed

Abstract

The loss of the SOST gene product sclerostin leads to sclerosteosis characterized by high bone mass. In this report, we found that sclerostin could antagonize canonical Wnt signaling in human embryonic kidney A293T cells and mouse osteoblastic MC3T3 cells. This sclerostin-mediated antagonism could be reversed by overexpression of Wnt co-receptor low density lipoprotein receptor-related protein (LRP) 5. In addition, we found that sclerostin bound to LRP5 as well as LRP6 and identified the first two YWTD-EGF repeat domains of LRP5 as being responsible for the binding. Although these two repeat domains are required for transduction of canonical Wnt signals, canonical Wnt did not appear to compete with sclerostin…

Citation impact

1,352
total citations
FWCI
16.68
Percentile
100%
References
40
Citations per year

Authors

8

Topics & keywords

Keywords
  • Sclerostin
  • Wnt signaling pathway
  • LRP5
  • Cell biology
  • LRP6
  • Chemistry
  • Internal medicine
  • Biology
No related works found for this paper.